Sarepta Therapeutics SRPT reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Sarepta Therapeutics beat estimated earnings by 8100.0%, reporting an EPS of $0.82 versus an estimate of $0.01.
Revenue was up $138.35 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.69 which was followed by a 2.0% increase in the share price the next day.
Here's a look at Sarepta Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.32 | -1.89 | -1.38 | -1.35 |
| EPS Actual | 0.37 | -0.85 | -0.97 | -0.53 |
| Revenue Estimate | 288.50M | 264.45M | 241.96M | 248.34M |
| Revenue Actual | 331.82M | 261.24M | 253.50M | 258.43M |
To track all earnings releases for Sarepta Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
